ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Mental Health
Psychedelic drugs could treat depression, and other mental illnesses
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 127440" data-attributes="member: 3"><p>The US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to psilocybin-assisted therapy from Compass Pathways for patients with treatment-resistant depression (TRD), the manufacturer reports.</p><p></p><p>This lays the groundwork for an upcoming multicountry study that will assess the safety and efficacy of psilocybin, the psychoactive ingredient in psychedelic or "magic" mushrooms.</p><p></p><p>Robin Carhart-Harris, PhD, head of the psychedelic research group, Imperial College London, United Kingdom, noted in a press release that he and a group of investigators "found promising signals of efficacy and safety as treatment" for refractory depression in their 2015 study.</p><p></p><p><a href="https://www.medscape.com/viewarticle/904159" target="_blank">Medscape: Medscape Access</a></p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 127440, member: 3"] The US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to psilocybin-assisted therapy from Compass Pathways for patients with treatment-resistant depression (TRD), the manufacturer reports. This lays the groundwork for an upcoming multicountry study that will assess the safety and efficacy of psilocybin, the psychoactive ingredient in psychedelic or "magic" mushrooms. Robin Carhart-Harris, PhD, head of the psychedelic research group, Imperial College London, United Kingdom, noted in a press release that he and a group of investigators "found promising signals of efficacy and safety as treatment" for refractory depression in their 2015 study. [URL="https://www.medscape.com/viewarticle/904159"]Medscape: Medscape Access[/URL] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Mental Health
Psychedelic drugs could treat depression, and other mental illnesses
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top